company

NYKIRKE BIOVARME AS

3180 NYKIRKE

Return on Equity
16,44 %
Current Ratio
0,52
Debt-to-Equity Ratio
−8,33
Key figures (NOK)2022
Revenue599 000
Net Income−71 000
Total Assets3 688 000
Total Equity−432 000
Income (NOK)2022
Revenue599 000
Expenditure614 000
Operating Profit0
Financial Income3 000
Financial Costs94 000
Financial Balance−91 000
Earnings Before Tax−91 000
Tax−20 000
Net Income−71 000
Balance (NOK)2022
Total Fixed Assets3 418 000
Total Current Assets270 000
Total Assets3 688 000
Total Retained Equity−1 432 000
Total Equity−432 000
Total Long-Term Debt3 599 000
Total Current Debt521 000
Total Equity and Debt3 688 000
Cash flow (NOK)2022
Sales Income580 000
Other Income19 000
Revenue599 000
Cost of Goods Sold227 000
Salary Costs22 000
Depreciation230 000
Impairment0
Expenditure614 000
Operating Profit0
Financial Income3 000
Financial Costs94 000
Financial Balance−91 000
Dividends0
Net Income−71 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets406 000
Real Eastate3 013 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets3 013 000
Total Fiancial Fixed Assets0
Total Fixed Assets3 418 000
Stock33 000
Total Investments0
Cash, Bank80 000
Total Current Assets270 000
Total Assets3 688 000
Total Equity−432 000
Short-Term Group Debt0
Total Long-Term Debt3 599 000
Creditors64 000
Unpaid Taxes10 000
Dividends0
Other Current Debt446 000
Total Current Debt521 000
Total Equity and Debt3 688 000
Financial indicators2022
Return on Equity16,44 %
Debt-to-Equity Ratio−8,33
Operating Profit Margin0 %
Current Ratio0,52
Quick Ratio0,55
Equity Ratio−0,12
Gross Profit Margin62,1 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English